{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T04:33:40Z","timestamp":1791347620241,"version":"4.3.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["B9RTPQ1"],"award-info":[{"award-number":["B9RTPQ1"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12936-017-1680-8","type":"journal-article","created":{"date-parts":[[2017,1,13]],"date-time":"2017-01-13T08:22:40Z","timestamp":1484295760000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":138,"title":["Rapid decline in the susceptibility of Plasmodium falciparum to dihydroartemisinin\u2013piperaquine in the south of Vietnam"],"prefix":"10.1186","volume":"16","author":[{"given":"Ngo Viet","family":"Thanh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4101-5706","authenticated-orcid":false,"given":"Nguyen","family":"Thuy-Nhien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nguyen Thi Kim","family":"Tuyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nguyen Thanh","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nguyen Thuy","family":"Nha-Ca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le Thanh","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huynh Hong","family":"Quang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Farrar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"Thwaites","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas J.","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel","family":"Wolbers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tran Tinh","family":"Hien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,1,13]]},"reference":[{"key":"1680_CR1","unstructured":"National Institute of Malariology Parasitology and Entomology. Report of National institute of malariology parasitology and entomology, 2015."},{"key":"1680_CR2","unstructured":"WHO. World malaria report 2014. Geneva: World Health Organization; 2014."},{"key":"1680_CR3","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1056\/NEJMoa1513137","volume":"374","author":"D M\u00e9nard","year":"2016","unstructured":"M\u00e9nard D, Khim N, Beghain J, Adegnika AA, Shafiul-Alam M, Amodu O, et al. A worldwide map of Plasmodium falciparum K13-propeller polymorphisms. N Engl J Med. 2016;374:2453\u201364.","journal-title":"N Engl J Med"},{"key":"1680_CR4","unstructured":"WHO. Global plan for artemisinin resistance containment. Geneva: World Health Organization; 2011."},{"key":"1680_CR5","unstructured":"WHO. Methods for surveillance of antimalarial drug efficacy. Geneva: World Health Organization; 2009."},{"key":"1680_CR6","unstructured":"Ministry of Health Portal VietNam. 2009. Guidelines for malaria diagnosis and treatment in VietNam."},{"key":"1680_CR7","unstructured":"WHO. Methods and techniques for clinical trial on antimalarial drug efficacy\u202f: genotyping to identify parasite populations. Geneva: World Health Organization; 2007."},{"key":"1680_CR8","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1073\/pnas.1211205110","volume":"110","author":"T-H Shannon","year":"2013","unstructured":"Shannon T-H, Clark TG, Jacob CG, Cummings MP, Miotto O, Dondorp AM, et al. Genetic loci associated with delayed clearance of Plasmodium falciparum following artemisinin treatment in Southeast Asia. Proc Natl Acad Sci USA. 2013;110:240\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1680_CR9","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/nature12876","volume":"505","author":"F Ariey","year":"2014","unstructured":"Ariey F, Witkowski B, Amaratunga C, Beghain J, Langlois AC, Khim N, et al. A molecular marker of artemisinin-resistant Plasmodium falciparum malaria. Nature. 2014;505:50\u20135.","journal-title":"Nature"},{"key":"1680_CR10","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/S1473-3099(13)70252-4","volume":"13","author":"B Witkowski","year":"2013","unstructured":"Witkowski B, Amaratunga C, Khim N, Sreng S, Chim P, Kim S, et al. Novel phenotypic assays for the detection of artemisinin-resistant Plasmodium falciparum malaria in Cambodia: in vitro and ex vivo drug-response studies. Lancet Infect Dis. 2013;13:1043\u20139.","journal-title":"Lancet Infect Dis"},{"key":"1680_CR11","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1186\/s12916-015-0539-5","volume":"13","author":"V Duru","year":"2015","unstructured":"Duru V, Khim N, Leang R, Kim S, Domergue A, Kloeung N, et al. Plasmodium falciparum dihydroartemisinin\u2013piperaquine failures in Cambodia are associated with mutant K13 parasites presenting high survival rates in novel piperaquine in vitro assays: retrospective and prospective investigations. BMC Med. 2015;13:305.","journal-title":"BMC Med"},{"key":"1680_CR12","doi-asserted-by":"crossref","unstructured":"Amato R, Lim P, Miotto O, Amaratunga C, Dek D, Pearson RD, et al. Genetic markers associated with dihydroartemisinin\u2013piperaquine failure in Plasmodium falciparum malaria in Cambodia: a genotype\u2013phenotype association study. Lancet Infect Dis. 2016; pii S1473-3099 (Epub ahead of print).","DOI":"10.1016\/S1473-3099(16)30409-1"},{"key":"1680_CR13","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1186\/1475-2875-10-339","volume":"10","author":"JA Flegg","year":"2011","unstructured":"Flegg JA, Guerin PJ, White NJ, Stepniewska K. Standardizing the measurement of parasite clearance in falciparum malaria: the parasite clearance estimator. Malar J. 2011;10:339.","journal-title":"Malar J."},{"key":"1680_CR14","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1186\/1475-2875-11-355","volume":"11","author":"TT Hien","year":"2012","unstructured":"Hien TT, Thuy-Nhien NT, Phu NH, Boni MF, Thanh NV, Nha-Ca NT, et al. In vivo susceptibility of Plasmodium falciparum to artesunate in Binh Phuoc Province, Vietnam. Malar J. 2012;11:355.","journal-title":"Malar J."},{"key":"1680_CR15","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1056\/NEJMoa1314981","volume":"371","author":"EA Ashley","year":"2014","unstructured":"Ashley EA, Dhorda M, Fairhurst RM, Amaratunga C, Lim P, Suon S, et al. Spread of artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med. 2014;371:411\u201323.","journal-title":"N Engl J Med"},{"key":"1680_CR16","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S1473-3099(15)00487-9","volume":"16","author":"C Amaratunga","year":"2016","unstructured":"Amaratunga C, Lim P, Suon S, Mao S, Sopha C, Sam B, et al. Dihydroartemisinin\u2013piperaquine resistance in Plasmodium falciparum malaria in Cambodia: a multisite prospective cohort study. Lancet Infect Dis. 2016;16:357\u201365.","journal-title":"Lancet Infect Dis."},{"key":"1680_CR17","doi-asserted-by":"crossref","first-page":"e758","DOI":"10.1016\/S2214-109X(15)00162-X","volume":"3","author":"TD Nguyen","year":"2015","unstructured":"Nguyen TD, Olliaro P, Dondorp AM, Baird JK, Lam HM, Farrar J, et al. Optimum population-level use of artemisinin combination therapies: a modelling study. Lancet Glob Health. 2015;3:e758\u201366.","journal-title":"Lancet Glob Health."},{"issue":"16","key":"1680_CR18","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/j.1708-8305.2009.00349.x","volume":"2009","author":"JD Markley","year":"2009","unstructured":"Markley JD, Edmond MB. Post-Malaria neurological syndrome: a case report and review of the literature. J Travel Med. 2009;2009(16):424\u201330.","journal-title":"J Travel Med."},{"key":"1680_CR19","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S1341-321X(06)70902-3","volume":"12","author":"Y Mizuno","year":"2006","unstructured":"Mizuno Y, Kato Y, Kanagawa S, Kudo K, Hashimoto M, Kunimoto M, et al. A case of postmalaria neurological syndrome in Japan. J Infect Chemother. 2006;12:399\u2013401.","journal-title":"J Infect Chemother."},{"key":"1680_CR20","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/S0140-6736(96)01409-2","volume":"348","author":"TH Nguyen","year":"1996","unstructured":"Nguyen TH, Day NP, Ly VC, Waller D, Mai NT, Bethell DB, et al. Post-malaria neurological syndrome. Lancet. 1996;348:917\u201321.","journal-title":"Lancet"},{"key":"1680_CR21","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1179\/000349803225001427","volume":"97","author":"PT Giao","year":"2003","unstructured":"Giao PT, Vries DP, Hung L, Binh T, Nam NV, Kager PA. Atovaquone\u2013proguanil for recrudescent Plasmodium falciparum in Vietnam. Ann Trop Med Parasitol. 2003;97:575\u201380.","journal-title":"Ann Trop Med Parasitol"},{"key":"1680_CR22","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1128\/AAC.02302-15","volume":"60","author":"DL Saunders","year":"2015","unstructured":"Saunders DL, Chaorattanakawee S, Gosi P, Lanteri C, Somethy S, Kuntawunginn W, et al. Atovaquone-proguanil remains a potential stopgap therapy for multidrug-resistant Plasmodium falciparum in areas along the Thai-cambodian border. Antimicrob Agents Chemother. 2015;60:1896\u20138.","journal-title":"Antimicrob Agents Chemother"},{"key":"1680_CR23","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1186\/1475-2875-13-380","volume":"13","author":"RJ Maude","year":"2014","unstructured":"Maude RJ, Nguon C, Dondorp AM, White LJ, White NJ. The diminishing returns of atovaquone\u2013proguanil for elimination of Plasmodium falciparum malaria: modelling mass drug administration and treatment. Malar J. 2014;13:380.","journal-title":"Malar J."},{"key":"1680_CR24","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1080\/14656566.2016.1187134","volume":"17","author":"NJ White","year":"2016","unstructured":"White NJ. Can new treatment developments combat resistance in malaria? Expert Opin Pharmacother. 2016;17:1303\u20137.","journal-title":"Expert Opin Pharmacother"}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-017-1680-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T04:11:48Z","timestamp":1498363908000},"score":1,"resource":{"primary":{"URL":"http:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/s12936-017-1680-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,13]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["1680"],"URL":"https:\/\/doi.org\/10.1186\/s12936-017-1680-8","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,13]]},"article-number":"27"}}